Cookies on the KCI website
We use cookies to improve your browsing experience on our website. Please visit Privacy Policy our for more information about cookies and how we use them. We recommend you to accept the use of cookies for better navigation.
Accessibility Help | Sitemap | Contact Us | Advantage Centre 24/7 - 0800 980 8880
United Kingdom Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home > News & Media
Print

News & Media

These press releases are intended as reference information for investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

Top Stories

KCI, Leader in Advanced Wound Care Solutions Acelity Acquires SNaP® Disposable Negative Pressure Wound Therapy System to Expand Offering in Portable, Non-Powered NPWT Technology

Acquisition accelerates Acelity’s strategy in the disposable negative pressure wound therapy market

KCI, Leader in Advanced Wound Care Solutions Acelity Increases Focus on Growth, Expansion Opportunities

 Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing

Headlines

Displaying 11 to 20 of 131 News
14th May 2015
Nanova™ Therapy System Now Available from Acelity

Device Combines Absorbent Dressing with Negative Pressure Facilitates Earlier Patient Discharge

17th February 2015
Acelity L.P. Inc. Reports Fourth Quarter and Full Year Financial Results for 2014

  • Fourth quarter revenue grew 6.5% compared to the prior-year period, on a constant currency basis
  • Fourth quarter 2014 Adjusted EBITDAfrom continuing operations1 grew 5.4% compared to the prior-year period, on a constant currency basis
  • Fourth quarter loss from continuing operations was $30.9 million compared to $52.0 million for the prioryear period
5th November 2014
Study Shows Positive Clinical and Potential Economic Outcomes with V.A.C. VeraFlo™ Therapy vs Standard V.A.C.® Therapy

Statistically Significant Reduction in Operating Room Debridements, Length of Therapy

3rd September 2014
KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity

Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue

1st July 2014
Novel KCI Skin Graft Harvesting Tool Now Available in Europe

CelluTome™ System takes autologous grafting out of the OR

Displaying 11 to 20 of 131 News

  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Legal Notice | Privacy Policy | Contact Us


Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193.UK
This information is intended only for residents of the United Kingdom.
The product information provided in this site is intended only for residents of the United Kingdom.
The products discussed herein may have different product labeling in different countries.